Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus

Cancer Research

Volumn 64, Issue 10, 2004, Pages 3414-3427

  Maley, Carlo C ^a,b   Galipeau, Patricia C ^a   Li, Xiaohong ^a   Sanchez, Carissa A ^a   Paulson, Thomas G ^a   Reid, Brian J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BARRETT ESOPHAGUS; CANCER GROWTH; CELL PROLIFERATION; CHROMOSOME 17; CHROMOSOME 9; CLONOGENESIS; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; ESOPHAGUS BIOPSY; EVOLUTION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENOMIC INSTABILITY; GENOMICS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; NEOPLASM; PRECANCER; PRIORITY JOURNAL; PROMOTER REGION; TISSUE FIXATION; TUMOR SUPPRESSOR GENE;

BARRETT ESOPHAGUS; DISEASE PROGRESSION; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; GENES, P16; GENES, P53; HUMANS; LOSS OF HETEROZYGOSITY; MUTATION; PLOIDIES;

EID: 2442649306     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3249     Document Type: Article

References (92)

1. Nowell PC. The clonal evolution of tumor cell populations. Science 1976;194:23-8.
2. Barrett MT, Sanchez CA, Prevo LJ, et al. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet 1999;22:106-9.
3. Gonzalez-Garcia I, Sole RV, Costa J. Metapopulation dynamics and spatial heterogeneity in cancer. Proc Natl Acad Sci USA 2002;99:13085-9.
4. Nicolson GL. Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression, Cancer Res 1987;47:1473-87.
5. Fujii H, Marsh C, Cairns P, Sidransky D, Gabrielson E. Genetic divergence in the clonal evolution of breast cancer. Cancer Res 1996;56:1493-7.
6. Poste G, Greig R. On the genesis and regulation of cellular heterogeneity in malignant tumors. Invasion and Metastasis 1982;2:137-76.
7. Endler JA. Natural Selection in the Wild, Vol. 21. Princeton: Princeton University Press, 1986.
8. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
9. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Eng J Med 1988;319:525-32.
10. Maitra A, Gazdar AF, Moore TO, Moore AY. Loss of heterozygosity analysis of cutaneous melanoma and benign melanocytic nevi: laser capture microdissection demonstrates clonal genetic changes in acquired nevocellular nevi. Hum Pathol 2002;33:191-7.
11. Gazdar AF, Bader S, Hung J, et al. Molecular genetic changes found in human lung cancer and its precursor lesions. Cold Spring Harb Symp Quant Biol 1994;59:565-72.
12. O'Connell P, Pekkel V, Fuqua SA, Osborne CK, Clark GM, Allred DC. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst 1998;90:697-703.
13. Neshat K, Sanchez CA, Galipeau PC, et al. Barrett's esophagus: a model of human neoplastic progression. Cold Spring Harbor Symp Quant Biol 1994;59:577-83.
14. Levine DS, Reid BJ. Endoscopic Diagnosis of Esophageal Neoplasms. Gastrointestinal Tumors 1992;2:395-413.
15. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002;97:1888-95.
16. Blount PL, Meltzer SJ, Yin J, Huang Y, Krasna MJ, Reid BJ. Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma. Proc Natl Acad Sci USA 1993;90:3221-5.
17. Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol 2000;95:1669-76.
18. Reid BJ, Prevo LJ, Galipeau PC, et al. Predictors of Progression in Barrett's Esophagus II: Baseline 17p (p53) Loss of Heterozygosity Identifies a Patient Subset at Increased Risk for Neoplastic Progression. Am J Gastroenterol 2001;96:2839-48.
19. Rabinovitch PS, Longton G, Blount PL, Levine DS, Reid BJ. Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables. Am J Gastroenterol 2001;96:3071-83.
20. Wild CP, Hardie LJ. Reflux, Barrett's Oesophagus and adenocarcinoma: Burning questions. Nat Rev Cancer 2003;3:676-85.
21. Barrett MT, Galipeau PC, Sanchez CA, Emond MJ, Reid BJ. Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene 1996;12:1873-8.
22. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Weber JL, Russell SE. Barrett's oesophagus: microsatellite analysis provides evidence to support the proposed metaplasia-dysplasia-carcinoma sequence. Genes, Chromosomes Cancer 1998;21:49-60.
23. INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas Cancer Res 1997;57:2619-22.
24. Riegman PH, Vissers KJ, Alers JC, et al. Genomic alterations in malignant transformation of Barrett's esophagus. Cancer Res 2001;61:3164-70.
25. Wong DJ, Paulson TG, Prevo LJ, et al. p16 INK4a lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res 2001;61:8284-9.
26. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003;63:1727-30.
27. Tomlinson IPM, Novelli MR, Bodmer WF. The Mutation Rate and Cancer. Proc Natl Acad Sci USA 1996;93:14800-3.
28. Luebeck EG, Moolgavkar SH. Simulating the Process Malig Trans Math Biosci 1994;123:127-46.
29. Sherman CD, Portier CJ. Stochastic simulation of a multistage model of carcinogenesis. Math Biosci 1996;134:35-50.
30. Maley CC, Forrest S. Exploring the relationship between neutral and selective mutations in cancer. Artificial Life 2000;6:325-45.
31. Hartl DL, Clark AG. Principles of Population Genetics. Sunderland, MA: Sinauer Associates, Inc., 1997.
32. Darwin C. On the Origin of Species. London: John Murray, 1859.
33. Fisher RA. The Genetical Theory of Natural Selection. Oxford, UK: Clarondon Press, 1930.
34. Kimura M. Evolutionary rate at the molecular level. Nature 1968;217:624-6.
35. Kimura M. Genetic variability maintained in a finite population due to mutational production of neutral and nearly neutral isoalleles. Genet Res 1968;11:247-69.
36. Smith JM, Haigh J. The hitch-hiking effect of a favourable gene. Genet Res 1974;23:23-35.
37. Renan MJ. How many mutations are required for tumorigenesis? implications from human cancer data. Mol Carcinog 1993;7:139-46.
38. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993;9:138-41.
39. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Creation of human tumour cells with defined genetic elements. Nature 1999;400:464-8.
40. Meltzer SJ, Yin J, Manin B, et al. Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinomas. Cancer Res 1994;54:3379-82.
41. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Weber JL, Russell SE. Ubiquitous somatic alterations at microsatellite alleles occur infrequently in Barrett's-associated esophageal adenocarcinoma. Cancer Res 1996;56:259-63.
42. Kulke MH, Thakore KS, Thomas G, et al. Microsatellite instability and hMLH1/hMSH2 expression in Barrett esophagus-associated adenocarcinoma. Cancer 2001;91:1451-7.
43. Mao L, Lee DJ, Tockman MS, Erozan YS, Askin F, Sidransky D. Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci USA 1994;91:9871-5.
44. Ahrendt SA, Decker PA, Doffek K, et al. Microsatellite instability at selected tetranucleotide repeats is associated with p53 mutations in non-small cell lung cancer. Cancer Res 2000;60:2488-91.
45. Danaee H, Nelson HH, Karagas MR, et al. Microsatellite instability at tetranucleotide repeats in skin and bladder cancer. Oncogene 2002;21:4894-9.
46. Dolan K, Garde J, Gosney J, et al. Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites. Br J Cancer 1998;78:950-7.
47. Hammoud ZT, Kaleem Z, Cooper JD, Sundaresan RS, Patterson GA, Goodfellow PJ. Allelotype analysis of esophageal adenocarcinomas: evidence for the involvement of sequences on the long arm of chromosome 4. Cancer Res 1996;56:4499-502.
48. Vogelstein B, Fearon ER, Kern SE, et al. Allelotype of colorectal carcinomas. Science 1989;244:207-11.
49. Bedi GC, Westra WH, Gabrielson E, Koch W, Sidransky D. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res 1996;56:2484-7.
50. Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 2001;32:368-78.
51. Ormsby AH, Perras RE, Henricks WH, et al. Interobserver variation in Barrett's (BE) related high-grade dysplasia (HGD) and superficial adenocarcinoma: can it be improved using uniform pathologic criteria? Gastroenterology 2000;118:A3764.
52. Alikhan M, Rex D, Khan A, Rahmani E, Cummings O, Ulbright TM. Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice. Gastrointestinal Endoscopy 1999;50:23-6.
53. Reid BJ, Haggitt RC, Rubin CE, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988;19:166-78.
54. Weston AP, Sharma P, Topalovski M, Cherian R, Dixon A. Low-grade dysplasia in Barrett's esophagus: variable fate during long-term prospective follow-up. Gastroenterology 1999;116:A352.
55. Conio M, Blanchi S, Lapertosa G, et al. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Am J Gastroenterol 2003;98:1931-9.
56. Sharma P, Falk G, Weston A, Reker D, Johnston M, Sampliner R. Natural history of low grade dysplasia - an infrequent finding which usually regresses - preliminary results from the barrett's esophagus study. Gastroenterology 2002;122:A20.
57. Paulson TG, Galipeau PC, Reid BJ. Loss of heterozygosity analysis using whole genome amplification, cell sorting, and fluorescence-based PCR. Genome Res 1999;9:482-91.
58. Reid BJ, Sanchez CA, Blount PL, Levine DS. Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression. Gastroenterology 1993;105:119-29.
59. Blount PL, Galipeau PC, Sanchez CA, et al. 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Cancer Res 1994;54:2292-5.
60. Rabinovitch PS. DNA content histogram and cell-cycle analysis. Methods Cell Biol 1994;41:263-96.
61. Barrett MT, Reid BJ, Joslyn G. Genotypic analysis of multiple loci in somatic cells by whole genome amplification. Nucleic Acids Res 1995;23:3488-92.
62. Galipeau PC, Prevo LJ, Sanchez CA, Longton GM, Reid BJ. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. J Natl Cancer Inst 1999;91:2087-95.
63. Wong DJ, Foster SA, Galloway DA, Reid BJ. Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M(0) growth arrest. Mol Cell Biol 1999;19:5642-51.
64. Prevo LJ, Sanchez CA, Galipeau PC, Reid BJ. p53-mutant clones and field effects in Barrett's esophagus. Cancer Res 1999;59:4784-7.
65. Efron B, Tibshirani R. The bootstrap (with discussion). Stat Sci 1986;1:54-77.
66. Good PI. Permutation Tests: A Practical Guide to Resampling Methods for Testing Hypotheses. New York: Springer-Verlag, 2000.
67. Stoler DL, Chen N, Basik M, et al. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc Natl Acad Sci USA 1999;96:15121-6.
68. Wiseman SM, Loree TR, Rigual NR, et al. Papillary thyroid cancer: High inter-(simple sequence repeat) genomic instability in a typically indolent cancer. Head Neck 2003;25:825-32.
69. Eads CA, Lord RV, Kurumboor SK, et al. Fields of Aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res 2000;60:5021-6.
70. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996;56:2488-92.
71. Califano J, Westra WH, Meininger G, Corio R, Koch WM, Sidransky D. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res 2000;6:347-52.
72. Hollstein M, Shomer B, Greenblatt M, et al. Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res 1996;24:141-6.
73. Ko LJ, Prives C. p53: puzzle and paradigm. Genes Dev 1996;10:1054-72.
74. Shao C, Deng L, Henegariu O, Liang L, Stambrook PJ, Tischfield JA. Chromosome instability contributes to loss of heterozygosity in mice lacking p53. Proc Natl Acad Sci USA 2000;97:7405-10.
75. Xia F, Wang X, Wang YH, Tsang NM, Yandell DW, Kelsey KT, Liber HL. Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines. Cancer Res 1995;55:12-5.
76. Honma M, Hayashi M, Sofuni T. Cytotoxic and mutagenic responses to X-rays and chemical mutagens in normal and p53-mutated human lymphoblastoid cells. Mutat Res 1997;374:89-98.
77. Martens UM, Zijlmans JM, Poon SS, et al. Short telomeres on human chromosome 17p. Nat Genet 1998;18:76-80.
78. Kinzler KW, Vogelstein B, Lessons from hereditary colorectal cancer. Cell 1996;87:159-70.
79. Newman WA. Dorland's Illustrated Medical Dictionary, 29 edition. Philadelphia: W. B. Saunders Co., 2000.
80. Gulizia JM, Wang H, Antonioli D, et al. Proliferative characteristics of intestinalized mucosa in the distal esophagus and gastroesophageal junction (short-segment Barrett's esophagus): a case control study. Hum Pathol 1999;30:412-8.
81. Gray MR, Hall PA, Nash J, Ansari B, Lane DP, Kingsnorth AN. Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalization. Gastroenterology 1992;103:1769-76.
82. Suspiro A, Pereira AD, Afonso A, et al. Losses of heterozygosity on chromosomes 9p and 17p are frequent events in Barrett's metaplasia not associated with dysplasia or adenocarcinoma. Am J Gastroenterol 2003;98:728-34.
83. Bian YS, Osterheld MC, Fontolliet C, Bosman FT, Benhattar J. p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus. Gastroenterology 2002;122:1113-21.
84. Bian Y, Osterheld M, Bosman F, Benhattar J, Fontolliet C. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Modern Pathology 2001;14:397-403.
85. Gimenez A, Minguela A, Parrilla P, et al. Flow cytometric DNA analysis and p53 protein expression show a good correlation with histologic findings in patients with Barrett's esophagus. Cancer 1998;83:641-51.
86. Montgomery EA, Hartmann DP, Carr NJ, Holterman DA, Sobin LH, Azumi N. Barrett esophagus with dysplasia. Flow cytometric DNA analysis of routine, paraffin-embedded mucosal biopsies. Am J Clin Pathol 1996;106:298-304.
87. Newton MA. Discovering combinations of genomic alterations associated with cancer. J Am Stat Assoc 2002;931-42.
88. Newton MA, Yang H, Gorman P, Tomlinson I, Roylance RA. Statistical approach to modeling genomic aberrations in cancer cells (with discussion). In: Bernardo JM, Bayarri MJ, Berger JO, Dawid AP, Hecherman D, Smith AFM, and West M, editors. Bayesian Statistics 7: Oxford University Press, 2003.
89. Chaturvedi V, Li L, Hodges S, et al. Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia. Oncogene 1997;14:2059-70.
90. Czerniak B, Chaturvedi V, Li L, et al. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer. Oncogene 1999;18:1185-96.
91. Czerniak B, Li L, Chaturvedi V, Ro JY, Johnston DA, Hodges S, Benedict WF. Genetic modeling of human urinary bladder carcinogenesis. Genes Chromosomes Cancer 2000;27:392-402.
92. Crow JF, Kimura M. An Introduction to Population Genetic Theory. New York: Harper and Row, 1970.